Abstract: The invention relates to a process for the treatment of glaucoma comprising administering to a human in need thereof an effective amount of a compound selected from the inhibitors of xanthine-oxidase.
Type:
Grant
Filed:
December 4, 1987
Date of Patent:
October 3, 1989
Assignee:
Laboratories Chauvin
Inventors:
Claude Bonne, Claude Coquelet, Elisabeth Latour